JD HEALTH
06618
BIDU-SW
09888
JD-SW
09618
ALI HEALTH
00241
BEKE-W
02423
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 24.18%26.47B | 1.31%44.26B | 4.98%21.32B | 23.15%43.69B | 19.68%20.31B | 24.80%35.48B | 29.95%16.97B | 2.39%28.43B | -5.69%13.06B | 19.80%27.76B |
Operating income | 24.18%26.47B | 1.31%44.26B | 4.98%21.32B | 23.15%43.69B | 19.68%20.31B | 24.80%35.48B | 29.95%16.97B | 2.39%28.43B | -5.69%13.06B | 19.80%27.76B |
Operating expenses | ||||||||||
Gross profit | ||||||||||
Selling expenses | -7.37%-1.32B | -208.94%-2.14B | ---1.23B | ---694.17M | ---- | ---- | ---- | ---- | ---- | ---- |
Employee expense | -42.03%-2.11B | -20.79%-4.64B | -12.89%-1.49B | -14.61%-3.84B | -11.67%-1.32B | -13.84%-3.35B | -0.93%-1.18B | -19.94%-2.94B | -2.98%-1.17B | -18.92%-2.45B |
Depreciation and amortization | -47.01%-6.07B | -18.53%-9.08B | -12.45%-4.13B | -25.60%-7.66B | -26.48%-3.67B | -14.62%-6.1B | -13.48%-2.9B | -10.45%-5.32B | -8.08%-2.56B | -23.33%-4.82B |
Special items of operating profit | 4.91%-9.5B | 17.61%-19.68B | 11.59%-9.99B | -14.19%-23.89B | -39.18%-11.3B | -51.70%-20.92B | -46.50%-8.12B | 8.12%-13.79B | 16.38%-5.54B | -17.35%-15.01B |
Operating profit | 66.72%7.47B | 14.61%8.72B | 11.50%4.48B | 48.93%7.6B | -15.69%4.02B | -19.87%5.11B | 25.82%4.76B | 16.25%6.37B | 1.94%3.79B | 24.17%5.48B |
Financing income | -46.13%94.54M | 81.69%279.12M | 93.21%175.5M | 21.34%153.62M | -4.44%90.83M | -61.68%126.6M | -18.42%95.06M | 122.42%330.35M | 69.23%116.52M | 18.02%148.53M |
Financing cost | -29.63%-2.58B | -0.30%-4.27B | 7.06%-1.99B | -10.34%-4.26B | -8.72%-2.14B | -20.53%-3.86B | -16.76%-1.97B | -1.19%-3.2B | -9.09%-1.68B | -22.79%-3.17B |
Share of profits of associates | 46.29%366.86M | 425.22%504.86M | 452.32%250.77M | 27.30%-155.23M | -166.37%-71.18M | -175.20%-213.52M | -27.51%107.25M | 26.37%283.95M | 18.04%147.95M | 96.31%224.7M |
Share of profit from joint venture company | 88.68%116.78M | 8,375.54%201.29M | 904.93%61.89M | 101.99%2.38M | -844.59%-7.69M | -373.20%-119.28M | -106.06%-814K | 71.39%43.66M | 898.46%13.44M | 495.21%25.48M |
Earning before tax | 83.54%5.47B | 62.28%5.43B | 57.60%2.98B | 222.09%3.34B | -36.96%1.89B | -72.86%1.04B | 26.00%3B | 40.97%3.83B | 0.73%2.38B | 31.12%2.71B |
Tax | -103.92%-877.05M | -35.51%-892.64M | 6.55%-430.09M | -82.00%-658.73M | -7.35%-460.24M | 59.81%-361.95M | 7.74%-428.74M | -75.55%-900.58M | 15.78%-464.71M | -18.54%-513.01M |
After-tax profit from continuing operations | 80.10%4.59B | 68.84%4.53B | 78.24%2.55B | 297.07%2.69B | -44.35%1.43B | -76.88%676.3M | 34.18%2.57B | 32.91%2.93B | 5.76%1.92B | 34.45%2.2B |
Earning after tax | 80.10%4.59B | 68.84%4.53B | 78.24%2.55B | 297.07%2.69B | -44.35%1.43B | -76.88%676.3M | 34.18%2.57B | 32.91%2.93B | 5.76%1.92B | 34.45%2.2B |
Minority profit | 155.68%1.79B | 3,787.38%1.45B | 20.56%699.92M | -96.00%37.29M | -43.57%580.55M | -23.39%932.55M | 38.52%1.03B | 32.78%1.22B | -11.01%742.72M | 70.14%916.77M |
Profit attributable to shareholders | 51.50%2.8B | 16.48%3.08B | 117.64%1.85B | 1,133.36%2.65B | -44.87%849.88M | -115.00%-256.26M | 31.44%1.54B | 33.01%1.71B | 20.09%1.17B | 16.94%1.28B |
Dividend | ---- | 20.00%1.63B | ---- | 151.21%1.36B | ---- | -57.51%541.67M | ---- | 0.00%1.27B | ---- | --1.27B |
Basic earnings per share | 50.00%0.21 | 0.00%0.22 | 100.00%0.14 | 650.00%0.22 | -53.33%0.07 | -123.53%-0.04 | 25.00%0.15 | 30.77%0.17 | 20.00%0.12 | 18.18%0.13 |
Diluted earnings per share | 50.00%0.21 | 0.00%0.22 | 100.00%0.14 | 650.00%0.22 | -53.33%0.07 | -123.53%-0.04 | 25.00%0.15 | 30.77%0.17 | 20.00%0.12 | 18.18%0.13 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.